Pasithea Therapeutics Corp Stock Probability of Future Stock Price Finishing Under 0.08
| KTTA Stock | USD 2.54 0.12 4.51% |
Pasithea |
Pasithea Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pasithea Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pasithea Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pasithea Therapeutics generated a negative expected return over the last 90 days | |
| Pasithea Therapeutics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 486.56 K. Net Loss for the year was (15.51 M) with loss before overhead, payroll, taxes, and interest of (2.21 K). | |
| Pasithea Therapeutics Corp currently holds about 47.94 M in cash with (12.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.8. | |
| Roughly 23.0% of the company outstanding shares are owned by corporate insiders |
Pasithea Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pasithea Stock often depends not only on the future outlook of the current and potential Pasithea Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pasithea Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.2 M | |
| Cash And Short Term Investments | 16.3 M |
Pasithea Therapeutics Technical Analysis
Pasithea Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Pasithea Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pasithea Therapeutics Corp. In general, you should focus on analyzing Pasithea Stock price patterns and their correlations with different microeconomic environments and drivers.
Pasithea Therapeutics Predictive Forecast Models
Pasithea Therapeutics' time-series forecasting models is one of many Pasithea Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pasithea Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Pasithea Therapeutics
Checking the ongoing alerts about Pasithea Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pasithea Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Pasithea Therapeutics generated a negative expected return over the last 90 days | |
| Pasithea Therapeutics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 486.56 K. Net Loss for the year was (15.51 M) with loss before overhead, payroll, taxes, and interest of (2.21 K). | |
| Pasithea Therapeutics Corp currently holds about 47.94 M in cash with (12.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.8. | |
| Roughly 23.0% of the company outstanding shares are owned by corporate insiders |
Check out Pasithea Therapeutics Backtesting, Pasithea Therapeutics Valuation, Pasithea Therapeutics Correlation, Pasithea Therapeutics Hype Analysis, Pasithea Therapeutics Volatility, Pasithea Therapeutics History as well as Pasithea Therapeutics Performance. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pasithea Therapeutics. If investors know Pasithea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pasithea Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pasithea Therapeutics is measured differently than its book value, which is the value of Pasithea that is recorded on the company's balance sheet. Investors also form their own opinion of Pasithea Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Pasithea Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pasithea Therapeutics' market value can be influenced by many factors that don't directly affect Pasithea Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pasithea Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pasithea Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pasithea Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.